Clinical Trial Update: Mobilization of Stem Cells With Plerixafor, Chemotherapy and G-CSF in Multiple Myeloma or Non-Hodgkin's Lymphoma Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating stem cell mobilization using plerixafor in combination with chemotherapy and G-CSF in patients with multiple myeloma or non-Hodgkin lym…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Non-hodgkin Lymphoma

Drugs mentioned

• Chemotherapy (chemotherapy)
• G-CSF (granulocyte colony-stimulating factor) (granulocyte colony-stimulating factor)
• Plerixafor (Plerixafor)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Lymphoma, Non-Hodgkin, Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2010-07-14